Tin tức & Cập nhật
Lọc theo Chuyên ngành:

Dupilumab eases itch, disease activity in chronic spontaneous urticaria
16 Mar 2025
bởiStephen Padilla
Patients with chronic spontaneous urticaria (CSA) who has uncontrolled disease despite treatment with H1-antihistamines may benefit from using dupilumab, which has been shown to reduce itch and urticaria activity in two phase III trials.